Showing results (271-280 of 296) with videos related to

Sort By:
Pageof 30
Medrxiv : the Preprint Server for Health Sciences|December 23, 2020
Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionalityWilliam Morgenlander, Stephanie Henson, Daniel Monaco, et al.
The Journal of Clinical Investigation|February 11, 2021
Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionalityWilliam R Morgenlander, Stephanie N Henson, Daniel R Monaco, et al.
Cell Host & Microbe|May 29, 2018
Genomic Epidemiology Reconstructs the Introduction and Spread of Zika Virus in Central America and MexicoJulien Thézé, Tony Li, Louis du Plessis, et al.
JCI Insight|December 2, 2021
Pharmacokinetics of high-titer anti-SARS-CoV-2 human convalescent plasma in high-risk childrenOren Gordon, Mary Katherine Brosnan, Steve Yoon, et al.
Transplantation Direct|December 30, 2021
Outcomes of SOT Recipients With COVID-19 in Different Eras of COVID-19 TherapeuticsAfrah S Sait, Teresa Po-Yu Chiang, Kieren A Marr, et al.
Trials|April 5, 2022
The Mirasol Evaluation of Reduction in Infections Trial (MERIT): study protocol for a randomized controlled clinical trialRonnie Kasirye, Heather A Hume, Evan M Bloch, et al.
Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of ConcernMaggie Li, Evan J Beck, Oliver Laeyendecker, et al.
Blood Advances|April 20, 2022
Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concernMaggie Li, Evan J Beck, Oliver Laeyendecker, et al.
Transfusion|March 30, 2022
How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?Evan M Bloch, Aaron A R Tobian, Shmuel Shoham, et al.
Transfusion|May 31, 2023
SARS-CoV-2 seroprevalence among blood donors in Uganda: 2019-2022Evan M Bloch, Dorothy Kyeyune, Jodie L White, et al.
Pageof 30